Hyperuricemia predicts mortality with chronic kidney disease
A study published in the Journal of Clinical Medicine indicates that hyperuricemia is an independent predictor of mortality in patients with chronic kidney disease. Researchers found a dose-response relationship, where higher serum uric acid levels correlate with increased risks of cardiac events and death.
Why it matters
This research suggests that uric acid levels could serve as a critical clinical marker for assessing systemic vulnerability and mortality risk in kidney disease patients.
edited by Gaby Clark , reviewed by Alexander Pol
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Add as preferred source Hyperuricemia independently predicts mortality in chronic kidney disease (CKD), according to a study published online July 13 in the Journal of Clinical Medicine .
Rasha Babiker, M.B.B.S., Ph.D., from Ras Al Khaimah Medical and Health Sciences University in the United Arab Emirates, and colleagues assessed whether hyperuricemia has prognostic significance for adverse outcomes in CKD. The analysis included 794 patients with CKD.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in